Devonian Health Group Inc. GSD.V Stock
Devonian Health Group Inc. Price Chart
Devonian Health Group Inc. GSD.V Financial and Trading Overview
| Devonian Health Group Inc. stock price | 0.22 CAD |
| Previous Close | 0.23 CAD |
| Open | 0.21 CAD |
| Bid | 0.2 CAD x 0 |
| Ask | 0.26 CAD x 0 |
| Day's Range | 0.21 - 0.21 CAD |
| 52 Week Range | 0.15 - 0.59 CAD |
| Volume | 1K CAD |
| Avg. Volume | 5.47K CAD |
| Market Cap | 34.51M CAD |
| Beta (5Y Monthly) | 1.521404 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GSD.V Valuation Measures
| Enterprise Value | 29.09M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.654967 |
| Price/Book (mrq) | 1.8918918 |
| Enterprise Value/Revenue | 13.195 |
| Enterprise Value/EBITDA | -10.927 |
Trading Information
Devonian Health Group Inc. Stock Price History
| Beta (5Y Monthly) | 1.521404 |
| 52-Week Change | -58.0000040% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.59 CAD |
| 52 Week Low | 0.15 CAD |
| 50-Day Moving Average | 0.22 CAD |
| 200-Day Moving Average | 0.32 CAD |
GSD.V Share Statistics
| Avg. Volume (3 month) | 5.47K CAD |
| Avg. Daily Volume (10-Days) | 14.21K CAD |
| Shares Outstanding | 144.36M |
| Float | 112.29M |
| Short Ratio | 1.48 |
| % Held by Insiders | 18.11% |
| % Held by Institutions | 0% |
| Shares Short | 9.35K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | -169.055% |
| Operating Margin (ttm) | -145.16% |
| Gross Margin | 37.67% |
| EBITDA Margin | -120.75% |
Management Effectiveness
| Return on Assets (ttm) | -9.17% |
| Return on Equity (ttm) | -23.17% |
Income Statement
| Revenue (ttm) | 2.2M CAD |
| Revenue Per Share (ttm) | 0.02 CAD |
| Quarterly Revenue Growth (yoy) | -13.50% |
| Gross Profit (ttm) | 561.02K CAD |
| EBITDA | -2661843 CAD |
| Net Income Avi to Common (ttm) | -3726621 CAD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.96M CAD |
| Total Cash Per Share (mrq) | 0.04 CAD |
| Total Debt (mrq) | 3.68M CAD |
| Total Debt/Equity (mrq) | 24.28 CAD |
| Current Ratio (mrq) | 1.497 |
| Book Value Per Share (mrq) | 0.111 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4124410 CAD |
| Levered Free Cash Flow (ttm) | -3434829 CAD |
Profile of Devonian Health Group Inc.
| Country | Canada |
| State | QC |
| City | Québec |
| Address | 360, rue des Entrepreneurs |
| ZIP | G5V 4T1 |
| Phone | N/A |
| Website | https://groupedevonian.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. The company was incorporated in 2015 and is headquartered in Québec, Canada.
Q&A For Devonian Health Group Inc. Stock
What is a current GSD.V stock price?
Devonian Health Group Inc. GSD.V stock price today per share is 0.22 CAD.
How to purchase Devonian Health Group Inc. stock?
You can buy GSD.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Devonian Health Group Inc.?
The stock symbol or ticker of Devonian Health Group Inc. is GSD.V.
Which industry does the Devonian Health Group Inc. company belong to?
The Devonian Health Group Inc. industry is Biotechnology.
How many shares does Devonian Health Group Inc. have in circulation?
The max supply of Devonian Health Group Inc. shares is 148.22M.
What is Devonian Health Group Inc. Price to Earnings Ratio (PE Ratio)?
Devonian Health Group Inc. PE Ratio is now.
What was Devonian Health Group Inc. earnings per share over the trailing 12 months (TTM)?
Devonian Health Group Inc. EPS is -0.02 CAD over the trailing 12 months.
Which sector does the Devonian Health Group Inc. company belong to?
The Devonian Health Group Inc. sector is Healthcare.